Cyprus biotech firm sees losses widen to €3.46m

Cyprus-based biotechnology company iDNA Genomics Public Ltd on Monday announced that it approved its audited consolidated financial statements for 2025, reporting a wider loss and a sharp deterioration in its balance sheet compared with the previous year. The company’s board approved its annual report and audited consolidated financial statements for the year ended December 31, […]